ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.445
+0.075 (5.47%)
Jul 24, 2026, 5:24 PM CET

STO:EXPRS2 Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
21.8447.5681.5457.6110.9737.11
Short-Term Investments
-----203.54
Cash & Short-Term Investments
21.8447.5681.5457.6110.97240.65
Cash Growth
-62.34%-41.68%41.57%-48.10%-53.89%125.26%
Accounts Receivable
1.031.191.190.950.831.62
Other Receivables
9.847.2111.489.619.975.48
Total Trade Receivables
10.878.412.6710.5610.797.11
Other Current Assets
10.311.581.150.5210.180.48
Total Current Assets
43.0257.5395.3668.67131.94146.46
Net Property, Plant & Equipment
0.270.471.541.770.911.21
Other Intangible Assets
1.411.52.082.472.953.14
Long-Term Investments
4.394.344.624.460.030.02
Other Long-Term Assets
1.321.271.321.321.531.12
Total Assets
50.465.11104.9178.69137.36151.96
Accounts Payable
1.644.048.471.8412.151.69
Short-Term Debt
0.520.50.360.281.761.92
Other Current Liabilities
20.8123.7129.429.2717.513.86
Total Current Liabilities
22.9628.2638.2511.3831.437.46
Other Long-Term Liabilities
1.021.161.871.952.614.15
Total Long-Term Liabilities
0.730.851.441.4423.48
Total Liabilities
23.6929.1139.6812.8233.4310.94
Common Stock
15.6915.6911.825.714.183.46
Additional Paid-in Capital
172.72207.08269.62529.75338.65266.24
Retained Earnings
-161.99-187.08-216.63-470.1-239.5-129.36
Shareholders' Equity
26.4235.6964.865.36103.33140.35
Total Liabilities & Equity
50.465.11104.9178.69137.36151.96
Total Debt
0.520.50.360.281.761.92
Net Cash (Debt)
21.3347.0581.1857.32109.21238.73
Net Cash Growth
-54.68%-42.04%41.62%-47.51%-54.25%127.49%
Net Cash Per Share
1.5716.5448.0149.70124.49326.57
Book Value
26.4235.6964.865.36103.33140.35
Book Value Per Share
1.9412.5438.3256.67117.78191.99
Tangible Book Value
25.0134.1862.7262.89100.37137.21
Tangible Book Value Per Share
1.8412.0237.0954.53114.42187.69